TABLE 1.
Participant characteristics
| Mean (SD) | Range | |
|---|---|---|
| Age, y | 54.0 (2.8) | 50-58 |
| Education, y | 16.4 (3.2) | 12-20 |
| LMP, mo | 29.3 (20.5) | 2-60 |
| FSH, IU/L | 76.0 (33.8) | 24-163 |
| Estradiol, pg/mL | 31.9 (32.9) | <20-128a |
| WASI-Full Scale IQ | 115.1 (14.3) | 94-141 |
| BADDS baseline | 38.6 (20.2) | 8-71 |
| n (%) | ||
| Perimenopausal | 4/14 (28.6) | |
| Postmenopausal | 10/14 (71.4) | |
| Previous OCP use | 11/14 (78.6) | |
| Previous HT use | 4/14 (28.6) |
LMP, last menstrual period; FSH, follicle-stimulating hormone; WASI, Wechsler Abbreviated Scale of Intelligence; BADDS, Brown Attention Deficit Disorder Scale; OCP, oral contraceptive pill; HT, hormone therapy.
a
Estradiol levels <20 pg/ml were converted to 19 pg/ml to compute mean circumference.